High-Intensity Rosuvastatin Dosing for Cardiovascular Risk Reduction

Definition and Classification

• High-intensity statin therapy is defined as treatment that lowers LDL cholesterol by ≥50% from baseline, with rosuvastatin 20 mg and 40 mg daily classified as high-intensity statin therapy by the American College of Cardiology 1, 2, 3, 4
• The American College of Cardiology recommends rosuvastatin 20 mg and 40 mg daily as high-intensity statin therapy, which reduces LDL cholesterol by ≥50% from baseline 1, 2, 4

Clinical Evidence and Guidelines

• The American College of Cardiology and the American Heart Association guideline specifically identifies rosuvastatin 20 mg (and 40 mg) as high-intensity statin therapy, which achieves a median LDL-C reduction of 50% and demonstrates significant ASCVD risk reduction 2, 5
• For patients requiring maximum ASCVD risk reduction, the American College of Cardiology recommends high-intensity statins (rosuvastatin 20-40 mg) to lower LDL-C by ≥50% 5
• In patients with clinical ASCVD, the American College of Cardiology recommends high-intensity statin therapy with rosuvastatin 20 mg to reduce ASCVD events 3, 7

Patient Considerations

• For patients ≥75 years of age, the American College of Cardiology suggests that the decision to use high-intensity rosuvastatin should be individualized based on risk-benefit assessment 3, 8